Interim analysis of NCT02458716: Feasibility of cytoreductive prostatectomy in men newly diagnosed with metastatic prostate cancer.
Yuh B, Kwon Y, Shinder B, Kim S, Lee N, Ruel N, Kim I. Interim analysis of NCT02458716: Feasibility of cytoreductive prostatectomy in men newly diagnosed with metastatic prostate cancer. Journal Of Clinical Oncology 2017, 35: e578-e578. DOI: 10.1200/jco.2017.35.6_suppl.e578.Peer-Reviewed Original ResearchMetastatic prostate cancerCytoreductive prostatectomyProstate cancerInterim analysisRate of incontinenceAndrogen deprivation therapyDeep venous thrombusMajor complication rateSecondary outcome measuresFirst interim analysisLocal tumor controlLong-term complicationsDeprivation therapyOncologic benefitPostoperative ileusIncontinence ratesPerioperative complicationsPrimary endpointAnastomotic leakComplication rateMinor complicationsLymph nodesMajor complicationsSubsequent therapyTumor control